World Health Organization site
Skip Navigation Links

Main
Note: This record shows only 22 elements of the WHO Trial Registration Data Set. To view changes that have been made to the source record, or for additional information about this trial, click on the URL below to go to the source record in the primary register.
Register: ChiCTR
Last refreshed on: 12 June 2023
Main ID:  ChiCTR2300071373
Date of registration: 2023-05-12
Prospective Registration: Yes
Primary sponsor: Shanghai YangZhi Rehabilitation Hospital (Shanghai Sunshine Rehabilitation Center)
Public title: Effect of low frequency repetitive transcranial magnetic stimulation on sleep disturbance in patients with amyotrophic lateral sclerosis.
Scientific title: Effect of low frequency repetitive transcranial magnetic stimulation on sleep disturbance in patients with amyotrophic lateral sclerosis.
Date of first enrolment: 2023-05-12
Target sample size: Routine rehabilitation training group + low frequency repetitive transcranial magnetic stimulation group:30;Routine rehabilitation training + low frequency repetitive transcranial magnetic stimulation sham stimulation group:30;
Recruitment status: Pending
URL:  https://www.chictr.org.cn/showproj.html?proj=197264
Study type:  Interventional study
Study design:  Parallel  
Phase:  0
Countries of recruitment
China
Contacts
Name: Hu yue   
Address:  No. 2209, Guangxing Road, Songjiang District, Shanghai
Telephone: +86 157 0006 0524
Email: 1303909837@qq.com
Affiliation:  Shanghai YangZhi Rehabilitation Hospital (Shanghai Sunshine Rehabilitation Center)
Name: LAN dan-mei   
Address:  No. 2209, Guangxing Road, Songjiang District, Shanghai
Telephone: +86 185 2130 8136
Email: landanmei2013@163.com
Affiliation:  Shanghai YangZhi Rehabilitation Hospital (Shanghai Sunshine Rehabilitation Center)
Key inclusion & exclusion criteria
Inclusion criteria: ? The age range from 18 to 80 years old, male and female;
? All ALS patients met clinically confirmed or probable ALS in the revised E1 Escorial criteria and Pittsburgh sleep quality index (PSQI) score =7;
(3) Mild to moderate disability (ALS-FRSR score: breathing score =3, other scores =2);
(4) To understand the whole process of the test, voluntarily participate in and sign the informed consent, provided by or legally authorized representatives.
? Have the communication ability required to participate in all tests.

Exclusion criteria: ? Patients with unstable disease or unable to cooperate with active training;
? There are listening comprehension disorders, visual impairment, hearing impairment, complete aphasia; Cognitive dysfunction (MMSE<21);
? Had a history of major surgery a week ago;
? Patients with the following complications: 1) severe liver and kidney function injury (ALT, AST, TBiL, Cr more than 50% of the upper limit of normal); 2) Abnormal mental state; 3) Complicated with malignant tumor, or history of malignant tumor;
? Pregnant or lactating women;
? Patients with contraindications of repetitive transcranial magnetic stimulation: such as epilepsy history, metal implantation history or pacemaker implantation history;
? Other conditions in which the investigator considers it impossible to participate in the clinical trial.


Age minimum: 18
Age maximum: 80
Gender: Both
Health Condition(s) or Problem(s) studied
Amyotrophic lateral sclerosis
Intervention(s)
Routine rehabilitation training group + low frequency repetitive transcranial magnetic stimulation group:Routine rehabilitation training program, including physical therapy, occupational therapy, speech swallowing therapy, 2 times a day, 30 minutes each time, 5 times a week, 20 times. On the basis of routine intervention, repeated transcranial magnetic stimulation therapy was completed every day, with each treatment lasting 20 minutes, 5 times a week, 20 times.;Routine rehabilitation training + low frequency repetitive transcranial magnetic stimulation sham stimulation group:On the basis of routine intervention, repeated transcranial magnetic stimulation (TMS) sham stimulation was performed daily for 20 minutes, 5 times a week.;
Primary Outcome(s)
Sleep efficiency in polysomnographic monitoring data;
Secondary Outcome(s)
Hamilton depression scale score;Hamilton anxiety scale score;ALSFRS-R score;ALSAQ-40 score;
Secondary ID(s)
Source(s) of Monetary Support
Multidisciplinary Management of Amyotrophic lateral Sclerosis, Shanghai Disabled Persons' Federation
Secondary Sponsor(s)
Ethics review
Status: Approved
Approval date: 08/02/2023
Contact:
shao ying-qi
+86 21 3773 0011
Results
Results available:
Date Posted:
Date Completed:
URL:
Disclaimer: Trials posted on this search portal are not endorsed by WHO, but are provided as a service to our users. In no event shall the World Health Organization be liable for any damages arising from the use of the information linked to in this section. None of the information obtained through use of the search portal should in any way be used in clinical care without consulting a physician or licensed health professional. WHO is not responsible for the accuracy, completeness and/or use made of the content displayed for any trial record.
Copyright - World Health Organization - Version 3.6 - Version history